68例冠心病患者临床治疗分析(1)
 |
| 第1页 |
参见附件。
【摘要】目的 总结阿托伐他汀在冠心病临床治疗中的应用。方法 对照组33例患者均给予常规治疗，即给予钙通道阻滞剂、抗凝剂、抗血小板聚集制剂、硝酸盐类、β-受体阻滞剂等治疗。若患者伴有高脂血症，则应给予必要的饮食治疗，且需添加脂必妥及血脂康等非他汀类降脂药。治疗组35例患者在对照组治疗的基础上给予阿托伐他汀治疗，40～80mg/次，每日1次，于睡前口服。结果 两组患者治疗前LDL-C、TG、TC及HDL-C水平对比，差异无统计学意义(P>0.05)；对照组治疗前后LDL-C、TG、TC及HDL-C水平对比，差异无统计学意义(P>0.05)；治疗组治疗前后LDL-C、TG、TC及HDL-C水平对比，差异存在统计学意义(P<0.05)；两组治疗后LDL-C、TG、TC及HDL-C水平对比，差异存在统计学意义(P<0.05)，证实治疗组降脂效果优于对照组；对照组缺血事件发生率为30.30%，治疗组缺血事件发生率为5.71%，治疗组缺血事件发生率明显低于对照组，其差异存在统计学意义(P<0.05)。结论 在冠心病临床治疗中，应用阿托伐他汀，可取得理想的治疗效果，值得推广使用。
【关键词】阿托伐他汀；冠心病；疗效
Clinical analysis of treatment of 68 cases of patients with coronary heart disease
Chen Jiemin Lan Jun Coated Chang Chen Benfa
Dongguan City Shilong people's Hospital Affiliated to Southern Medical University Guangdong Dongguan 523321
【Abstract】Objective to summarize the effects of atorvastatin in coronary heart disease clinical application. Methods 33 cases in control group were given conventional treatment, i.e. given calcium channel blockers, anticoagulant, antiplatelet agents, nitrates, beta blockers in treatment of. If the patients complicated with hyperlipidemia, should give necessary dietary therapy, and the need to add Zhibituo and dyslipidemia and other non lipid-lowering statins. The treatment group 35 cases in the control group treated with atorvastatin therapy, 40 ～80mg/, 1 times a day, at bedtime oral. The results of two groups of patients before treatment, LDL-C, TG, TC and HDL-C level comparison, the difference was not statistically significant (P>0 ......
您现在查看是摘要介绍页，详见PDF附件(2218kb)。